Expertise in
8
conditions

Dr. Abha A. Gupta

Obstetrics and Gynecology
Dedicated To Women OB/GYN (Milford)
806 Seabury Ave, 
Milford, DE 
Accepting New Patients
Expertise in
8
conditions
Dedicated To Women OB/GYN (Milford)
806 Seabury Ave, 
Milford, DE 

Overview

Abha Gupta is an Obstetrics and Gynecologist practicing medicine in Milford, Delaware.

Dr. Gupta is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Gallbladder Disease, Pelvic Inflammatory Disease, Vulvovaginitis, Intrauterine Device Insertion, and Vaginectomy.

She is actively involved in clinical research, co-authoring 200 peer reviewed articles and participating in 10 clinical trials. Dr. Gupta is currently accepting new patients.

Specialties

Obstetrics and Gynecology

Licenses

Obstetrics & Gynecology in DE

Hospital Affiliations

Tidalhealth Nanticoke, Inc.
Beebe Medical Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Golden Rule
  • INSURANCE PLAN
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Nippon Life
  • INSURANCE PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Dedicated to Women OB/GYN (Milford)
806 Seabury Ave, Milford, DE 19963

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating With Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864) in Patients With Intermediate Risk (IR) Rhabdomyosarcoma (RMS)
A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating With Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864) in Patients With Intermediate Risk (IR) Rhabdomyosarcoma (RMS)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Radiation, Drug, Biological, Other
Study Drugs: Cyclophosphamide, Dactinomycin, Irinotecan hydrochloride, Temsirolimus, Vincristine sulfate, Vinorelbine
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Nirogacestat Versus Placebo in Adult Patients With Progressing Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Nirogacestat Versus Placebo in Adult Patients With Progressing Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
Enrollment Status: Completed
Publish Date: August 20, 2026
Intervention Type: Drug
Study Drug: Nirogacestat Oral Tablet
Study Phase: Phase 3
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Enrollment Status: Active_not_recruiting
Publish Date: July 29, 2026
Intervention Type: Drug, Procedure, Biological, Radiation
Study Drugs: Cyclophosphamide, Doxorubicin, Doxorubicin Hydrochloride, Etoposide, Etoposide Phosphate, Ganitumab, Ifosfamide, Vincristine, Vincristine Sulfate
Study Phase: Phase 3
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754)
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754)
Enrollment Status: Completed
Publish Date: June 17, 2026
Intervention Type: Drug, Radiation, Procedure
Study Drugs: Doxorubicin, Ifosfamide, Pazopanib
Study Phase: Phase 2/Phase 3
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Enrollment Status: Completed
Publish Date: June 22, 2025
Intervention Type: Drug
Study Drug: Tazemetostat
Study Phase: Phase 2
A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Enrollment Status: Completed
Publish Date: October 03, 2024
Intervention Type: Drug
Study Drug: Tazemetostat
Study Phase: Phase 1
A Phase 2 Study of Human-Mouse Chimeric Anti-disialoganglioside Monoclonal Antibody ch14.18 (Dinutuximab, NSC# 764038) in Combination With Sargramostim (GM-CSF) in Patients With Recurrent Osteosarcoma
A Phase 2 Study of Human-Mouse Chimeric Anti-disialoganglioside Monoclonal Antibody ch14.18 (Dinutuximab, NSC# 764038) in Combination With Sargramostim (GM-CSF) in Patients With Recurrent Osteosarcoma
Enrollment Status: Completed
Publish Date: October 26, 2023
Intervention Type: Other, Biological
Study Drugs: Dinutuximab, Sargramostim
Study Phase: Phase 2
Assessing the Safety, Feasibility, Cost Effectiveness and Patient Satisfaction of Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma
Assessing the Safety, Feasibility, Cost Effectiveness and Patient Satisfaction of Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma
Enrollment Status: Completed
Publish Date: October 28, 2021
Intervention Type: Drug
Study Phase: Phase 3
Genomic Basis of Neurodevelopmental and Brain Outcomes in Congenital Heart Disease
Genomic Basis of Neurodevelopmental and Brain Outcomes in Congenital Heart Disease
Enrollment Status: Completed
Publish Date: August 13, 2020
Intervention Type: Other
View 8 Less Clinical Trials

200 Total Publications

Genetic Etiologies and Risk Factors for Regressive Autism and Childhood Disintegrative Disorder: A Scoping Review.
Genetic Etiologies and Risk Factors for Regressive Autism and Childhood Disintegrative Disorder: A Scoping Review.
Journal: Journal of child neurology
Published: July 06, 2026
Similar Doctors
Expertise in
16
conditions
Dr. Suneet P. Chauhan
Obstetrics and Gynecology
Expertise in
16
conditions
Dr. Suneet P. Chauhan
Obstetrics and Gynecology
Referral may be required
Before you request

The Delaware Center For Maternal And Fetal Medicine Of Christiana Care

1 Centurian Dr, 
Newark, DE 
 (56.2 miles away)
302-319-5680
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Suneet Chauhan is an Obstetrics and Gynecologist practicing medicine in Newark, Delaware. Dr. Chauhan is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Small for Gestational Age, Intrauterine Growth Restriction, Intraventricular Hemorrhage of the Newborn, Hysterectomy, and Salpingo-Oophorectomy. Dr. Chauhan is board certified in American Board Of Obstetrics And Gynecology. Dr. Chauhan is currently accepting new patients.

Expertise in
31
conditions
Dr. Fouad M. Abbas
Obstetrics and Gynecology
Expertise in
31
conditions
Dr. Fouad M. Abbas
Obstetrics and Gynecology
Referral may be required

University Of Maryland Easton

598 Cynwood Drive, Suite 105, 
Easton, MD 
 (35.1 miles away)
410-822-1221
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients
Offers Telehealth

Fouad Abbas is an Obstetrics and Gynecologist practicing medicine in Easton, Maryland. Dr. Abbas is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Sertoli-Leydig Cell Tumor, Oophorectomy, and Ureteroscopy. Dr. Abbas is board certified in American Board Of Obstetrics & Gynecology - Gynecological Oncology, 1995 and American Board Of Obstetrics And Gynecology - Obstetrics And Gynecology, 1993. Dr. Abbas is currently accepting new patients.

Expertise in
11
conditions
Dr. Howard B. Goldstein
Obstetrics and Gynecology
Expertise in
11
conditions
Dr. Howard B. Goldstein
Obstetrics and Gynecology
Referral may be required
Before you request

Center For Urogynecology And Pelvic Surgery Smyrna

100 South Main Street, Suite 215, 
Smyrna, DE 
 (29.0 miles away)
302-623-4055
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Howard Goldstein is an Obstetrics and Gynecologist practicing medicine in Smyrna, Delaware. Dr. Goldstein is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Urinary Incontinence, Stress Urinary Incontinence, Uterine Prolapse, Rectocele, and Bladder Reconstruction. Dr. Goldstein is board certified in American Board Of Obstetrics And Gynecology Subsp Urogynecology And Reconstructive Pelvic Surgery and American Board Of Obstetrics And Gynecology. Dr. Goldstein is currently accepting new patients.

Frequently Asked Questions about Dr. Abha A. Gupta

How do I make an appointment with Dr. Abha A. Gupta?

You can book an appointment with Dr. Abha A. Gupta by calling their office at 302-674-0223. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Abha A. Gupta a top-rated expert for Gallbladder Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Abha A. Gupta is classified as an Distinguished expert for Gallbladder Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Abha A. Gupta specialize in?

While Dr. Abha A. Gupta is a Obstetrics and Gynecology, they have specific expertise in Gallbladder Disease, Pelvic Inflammatory Disease, and Vulvovaginitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Obstetrics and Gynecology.

Does Dr. Abha A. Gupta participate in research or clinical trials?

Yes. Dr. Abha A. Gupta has published 200 articles and abstracts on conditions like Gallbladder Disease. You can view a list of Dr. Abha A. Gupta's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Abha A. Gupta accept my insurance?

Dr. Abha A. Gupta accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 302-674-0223 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gupta's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 47 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile